Is Hims & Hers the next big player in telehealth? Our experts break down its business model, growth potential, and the risks ...

Hims & Hers Health is upgraded to a speculative Buy after a 20% drop, with growth potential in GLP-1 sales outweighing key ...

HIMS accelerates global expansion with tech-integrated care, leveraging ZAVA and semaglutide for personalized health delivery.

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of ...

Eli Lilly stock dips despite strong Q2 results. Read my insights on obesity drug market dominance and why this selloff in LLY ...

Novo Nordisk’s head of U.S. marketing, Ulrich Otte, is no longer in the role and is exploring other internal opportunities at the company outside of the U.S.

Novo Nordisk A/S (NYSE: NVO) is one of the top oversold NYSE stocks to buy now. In a report released on August 4, Emily Field from Barclays maintained a Hold rating on Novo Nordisk A/S (NYSE:NVO), ...

For the quarter ended June 2025, Adient (ADNT) reported revenue of $3.74 billion, up 0.7% over the same period last year. EPS ...

Lyft (LYFT) reported $1.59 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 10.6 ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Detailed price information for Highpeak Energy Inc (HPK-Q) from The Globe and Mail including charting and trades.